The FDA authorized a brand new Alzheimer’s therapy known as donanemab on Tuesday. It is designed to assist sufferers within the early levels of the illness. CBS News chief medical correspondent Dr. Jon LaPook explains what to know.
Each weekday morning, "CBS Mornings" co-hosts Gayle King, Tony Dokoupil and Nate Burleson deliver you the most recent breaking information, good dialog and in-depth characteristic reporting. "CBS Mornings" airs weekdays at 7 a.m. on CBS and stream it at 8 a.m. ET on the CBS News app.
Subscribe to "CBS Mornings" on YouTube: https://youtube.com/CBSMornings
Watch CBS News 24/7: https://cbsnews.com/live/
Download the CBS News app: https://cbsnews.com/mobile/
Follow "CBS Mornings" on Instagram: https://instagram.com/cbsmornings/
Like "CBS Mornings" on Facebook: https://facebook.com/CBSMornings
Follow "CBS Mornings" on X: https://twitter.com/CBSMornings
Subscribe to our e-newsletter: https://cbsnews.com/newsletters/
Try Paramount+ free: https://paramountplus.com/?ftag=PPM-05-10aeh8h
For video licensing inquiries, contact: [email protected]
